136 related articles for article (PubMed ID: 33335896)
1. Cepharanthine as a Potential Novel Tumor-Regional Therapy in Treating Cutaneous Melanoma: Altering the Expression of Cathepsin B, Tumor Suppressor Genes and Autophagy-Related Proteins.
Liu Y; Xie Y; Lin Y; Xu Q; Huang Y; Peng M; Lai W; Zheng Y
Front Bioeng Biotechnol; 2020; 8():601969. PubMed ID: 33335896
[TBL] [Abstract][Full Text] [Related]
2. Cepharanthine exerts antitumor activity on choroidal melanoma by reactive oxygen species production and c-Jun N-terminal kinase activation.
Zhu Q; Guo B; Chen L; Ji Q; Liang H; Wen N; Zhang L
Oncol Lett; 2017 May; 13(5):3760-3766. PubMed ID: 28529590
[TBL] [Abstract][Full Text] [Related]
3. Identification of a novel autophagic inhibitor cepharanthine to enhance the anti-cancer property of dacomitinib in non-small cell lung cancer.
Tang ZH; Cao WX; Guo X; Dai XY; Lu JH; Chen X; Zhu H; Lu JJ
Cancer Lett; 2018 Jan; 412():1-9. PubMed ID: 29024815
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of MYO1C mediated by cepharanthine inhibits autophagosome-lysosome fusion through blockade of the F-actin network.
Zhang Y; Jiang X; Deng Q; Gao Z; Tang X; Fu R; Hu J; Li Y; Li L; Gao N
J Exp Clin Cancer Res; 2019 Nov; 38(1):457. PubMed ID: 31699152
[TBL] [Abstract][Full Text] [Related]
5. Cepharanthine exhibits a potent anticancer activity in p53-mutated colorectal cancer cells through upregulation of p21Waf1/Cip1.
Rattanawong A; Payon V; Limpanasittikul W; Boonkrai C; Mutirangura A; Wonganan P
Oncol Rep; 2018 Jan; 39(1):227-238. PubMed ID: 29138869
[TBL] [Abstract][Full Text] [Related]
6. Cepharanthine Induces Autophagy, Apoptosis and Cell Cycle Arrest in Breast Cancer Cells.
Gao S; Li X; Ding X; Qi W; Yang Q
Cell Physiol Biochem; 2017; 41(4):1633-1648. PubMed ID: 28359054
[TBL] [Abstract][Full Text] [Related]
7. Tetrandrine and cepharanthine induce apoptosis through caspase cascade regulation, cell cycle arrest, MAPK activation and PI3K/Akt/mTOR signal modification in glucocorticoid resistant human leukemia Jurkat T cells.
Xu W; Wang X; Tu Y; Masaki H; Tanaka S; Onda K; Sugiyama K; Yamada H; Hirano T
Chem Biol Interact; 2019 Sep; 310():108726. PubMed ID: 31255635
[TBL] [Abstract][Full Text] [Related]
8. Cepharanthine attenuates cerebral ischemia/reperfusion injury by reducing NLRP3 inflammasome-induced inflammation and oxidative stress via inhibiting 12/15-LOX signaling.
Zhao J; Piao X; Wu Y; Liang S; Han F; Liang Q; Shao S; Zhao D
Biomed Pharmacother; 2020 Jul; 127():110151. PubMed ID: 32559840
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of Tanshinone II a inhibits malignant melanoma development through blocking autophagy signal transduction in A375 cell.
Li X; Li Z; Li X; Liu B; Liu Z
BMC Cancer; 2017 May; 17(1):357. PubMed ID: 28532456
[TBL] [Abstract][Full Text] [Related]
10. Kalantuboside B induced apoptosis and cytoprotective autophagy in human melanoma A2058 cells: An in vitro and in vivo study.
Hseu YC; Cho HJ; Gowrisankar YV; Thiyagarajan V; Chen XZ; Lin KY; Huang HC; Yang HL
Free Radic Biol Med; 2019 Nov; 143():397-411. PubMed ID: 31442557
[TBL] [Abstract][Full Text] [Related]
11. Mechanism of Cepharanthine Cytotoxicity in Human Ovarian Cancer Cells.
Payon V; Kongsaden C; Ketchart W; Mutirangura A; Wonganan P
Planta Med; 2019 Jan; 85(1):41-47. PubMed ID: 30142661
[TBL] [Abstract][Full Text] [Related]
12. Biscoclaurine alkaloid cepharanthine inhibits the growth of primary effusion lymphoma in vitro and in vivo and induces apoptosis via suppression of the NF-kappaB pathway.
Takahashi-Makise N; Suzu S; Hiyoshi M; Ohsugi T; Katano H; Umezawa K; Okada S
Int J Cancer; 2009 Sep; 125(6):1464-72. PubMed ID: 19521981
[TBL] [Abstract][Full Text] [Related]
13. Current status and future challenges in extraction, purification and identification of Cepharanthine (a potential drug against COVID-19).
Wang Y; Zhou X; Wei S; Wang G; Xi J
Sep Purif Technol; 2023 Mar; 309():123038. PubMed ID: 36593875
[TBL] [Abstract][Full Text] [Related]
14. Activity, expression, and transcription rate of the cathepsins B, D, H, and L in cutaneous malignant melanoma.
Fröhlich E; Schlagenhauff B; Möhrle M; Weber E; Klessen C; Rassner G
Cancer; 2001 Mar; 91(5):972-82. PubMed ID: 11251949
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of signal transducer and activator of transcription 3 and cyclooxygenase-2 is involved in radiosensitization of cepharanthine in HeLa cells.
Fang ZH; Li YJ; Chen Z; Wang JJ; Zhu LH
Int J Gynecol Cancer; 2013 May; 23(4):608-14. PubMed ID: 23466568
[TBL] [Abstract][Full Text] [Related]
16. Induction of cell cycle arrest and apoptosis in myeloma cells by cepharanthine, a biscoclaurine alkaloid.
Kikukawa Y; Okuno Y; Tatetsu H; Nakamura M; Harada N; Ueno S; Kamizaki Y; Mitsuya H; Hata H
Int J Oncol; 2008 Oct; 33(4):807-14. PubMed ID: 18813795
[TBL] [Abstract][Full Text] [Related]
17. Cepharanthine suppresses metastatic potential of human cholangiocarcinoma cell lines.
Uthaisar K; Seubwai W; Srikoon P; Vaeteewoottacharn K; Sawanyawisuth K; Okada S; Wongkham S
Asian Pac J Cancer Prev; 2012; 13 Suppl():149-54. PubMed ID: 23480757
[TBL] [Abstract][Full Text] [Related]
18. In vivo augmentation of the intratumoral concentration of 5-fluorouracil by cepharanthine--a biscoclaurine alkaloid.
Tanaka N; Kataoka K; Muro M; Kojima K; Horiki S; Ono M; Moreira LF; Naomoto Y; Orita K
In Vivo; 1994; 8(3):309-11. PubMed ID: 7803709
[TBL] [Abstract][Full Text] [Related]
19. Cepharanthine inhibits in vitro VSMC proliferation and migration and vascular inflammatory responses mediated by RAW264.7.
Paudel KR; Karki R; Kim DW
Toxicol In Vitro; 2016 Aug; 34():16-25. PubMed ID: 27021874
[TBL] [Abstract][Full Text] [Related]
20. Targeting negative regulation of p53 by MDM2 and WIP1 as a therapeutic strategy in cutaneous melanoma.
Wu CE; Esfandiari A; Ho YH; Wang N; Mahdi AK; Aptullahoglu E; Lovat P; Lunec J
Br J Cancer; 2018 Feb; 118(4):495-508. PubMed ID: 29235570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
